Bristol-Myers Squibb sell Morgan Stanley
Start price
19.07.23
/
50%
€55.70
Target price
19.07.24
€52.70
Performance (%)
-30.56%
End price
20.07.24
€38.68
Summary
This prediction ended on 20.07.24 with a price of €38.68. Morgan_Stanley correctly predicted massive losses of -30.56% for Bristol-Myers Squibb. Morgan_Stanley has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Sell. Dividends of €2.19 are taken into consideration when calculating the performance. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 4.746% | 4.746% | -22.301% |
| iShares Core DAX® | 2.147% | 2.681% | 17.410% |
| iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% |
| iShares Nikkei 225® | 0.635% | 3.079% | 16.921% |
| iShares S&P 500 | 0.746% | 0.171% | 23.802% |
Comments by Morgan_Stanley for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $59.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
11.10.23
11.10.23
€52.70
11.10.24
11.10.24
-12.61%
15:53
15:53
Stopped prediction by Morgan_Stanley for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.80
27.10.23
27.10.23
€47.31
27.10.24
27.10.24
-6.30%
15:53
15:53